Back to Trades
Greenstreet Yvonne
Chief Executive OfficerDirectorCIK 0001446125
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 72
- Companies
- 1
- Active
- 2025–2026
Greenstreet Yvonne, Chief Executive Officer, Director, has filed 8 SEC reports (2025–2026), all concentrated in ALNYLAM PHARMACEUTICALS, INC. (ALNY), totaling $44.1M in disclosed volume. Weighing $0 bought versus $26.7M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Mar 4 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer, Director | Sell | $2.2M |
| Mar 2 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer, Director | Exercise | $0 |
| Feb 17 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer, Director | Sell | $2.2M |
| Jan 14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer, Director | Sell | $3.5M |
| Dec 1 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer, Director | Exercise | $1.5M |
| Nov 14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer, Director | Sell | $11.6M |
| Oct 3 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer, Director | Sell | $4.0M |
| Aug 19 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer, Director | Sell | $3.2M |
8 filings